2002
New Stabilizer Systems Designed to Make Procedure Available to More Patients Brussels, Belgium and Mainz, Germany - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company to Host Webcast/Conference Call Today Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today reported preliminary results of...
Clinical Trial Fully Enrolled In Less Than Four Months Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it has...
Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today issued the following statement on the status of its international ACTION...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...
Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...
Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...
ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...